title: PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population.
abstract: Oxidative stress has been suggested to contribute to the development of non-alcoholic fatty liver disease (NAFLD). Peroxisome proliferator-activated receptor gamma (PPAR-γ) heterozygous mice and Pro12Ala (C/G) polymorphism in PPARG exhibited increased resistance to oxidative stress. Smoking increases the production of reactive oxygen species, which could accelerates oxidative stress under overnutrition. To explore whether the C/G polymorphism, alone or in combination with smoking, may promote the development of non-alcoholic fatty liver, a case-control study was performed in 903 Chinese subjects. Among the study population, 436 patients with B-mode ultrasound-proven NAFLD (318 with steatosis hepatis I°, 90 with steatosis hepatis II° and 28 with steatosis hepatis III°) and 467 controls were genotyped by using TaqMan allelic discrimination assays. After adjusting for confounders, the C/C genotype significantly associated with NAFLD (OR=1.87, 95%CI 1.13-2.85, p=0.009); smoking was also an independent risk factor for NAFLD (OR=1.69, 95%CI 1.18-2.43, p=0.025). In addition, we found possible synergistic effects, the higher risk group (smokers with the C/C genotype) showed 3.75 times higher risk of NAFLD than the low-risk group (non-smokers with C/G genotype) in a multiple logistic analysis after adjusting for the confounders (p<0.001), but no departure from additivity was found. Our results indicated that the C/C genotype and smoking were significant independent risk factors for NAFLD. The possible synergistic effects of genotype and smoking may promote the development of NAFLD by aggravating oxidative stress, which supports the hypothesis that oxidative stress contributes to the development of NAFLD.
authors.affiliation: Department of Endocrinology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, 301 Middle Yanchang Road, Shanghai, China. yangzhen1020@hotmail.com
authors.forename: Zhen
authors.initials: Z
authors.lastname: Yang
authors.forename: Jie
authors.initials: J
authors.lastname: Wen
authors.forename: Qin
authors.initials: Q
authors.lastname: Li
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Tao
authors.forename: Zi
authors.initials: Z
authors.lastname: Ye
authors.forename: Min
authors.initials: M
authors.lastname: He
authors.forename: Weiwei
authors.initials: W
authors.lastname: Zhang
authors.forename: Ying
authors.initials: Y
authors.lastname: Huang
authors.forename: Lili
authors.initials: L
authors.lastname: Chen
authors.forename: Charlotte
authors.initials: C
authors.lastname: Ling
authors.forename: Shen
authors.initials: S
authors.lastname: Qu
authors.forename: Renming
authors.initials: R
authors.lastname: Hu
mesh_terms: D000368:Aged; D019943:Amino Acid Substitution; D002681:China; D003430:Cross-Sectional Studies; D005234:Fatty Liver / Q000209:etiology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D056726:Genetic Association Studies; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease; D047495:PPAR gamma / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D047495:PPAR gamma